investordatabase.org

Tachyon Ventures

tachyon.vc Direct + LP

Tachyon Ventures is a specialist biotech investment firm that backs early-stage biotech companies in the US and Europe and acquires limited partner interests in biotech venture funds. Its strategies span company formation, early-stage venture investing and secondaries.

Tachyon Ventures is a venture capital firm. It invests both directly in companies and in funds as a limited partner, from pre-seed to Series A, in biotech, therapeutics, delivery and molecule.

“We back early-stage biotech companies and acquire LP interests in biotech venture funds.”

— Tachyon Ventures, own website
Layer
Direct + LP
Type
Venture capital
Stage
Pre-seed – Series A
Invests in
United States, Europe
Sectors
biotech, therapeutics, delivery, molecule, target biology, diagnostics, bioengineering

Team, as Tachyon Ventures publishes it

  • Cristina Escoda Managing Partner
  • Ernest Turro Chief Scientific Partner
  • Josep Turro Partner, Investment Committee
  • Neil Deramchi Principal, US Venture
  • Thomas Dadashi Partner, Head of Secondaries
  • Jaime Vazquez Venture Partner, Secondaries
  • Albert Cot Venture Partner, Europe
  • Elena Canetti Senior Advisor, Tech Transfer, Europe
  • Jesus Purroy Advisor, Research Institutions, Europe

Names and roles exactly as listed on tachyon.vc. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Tachyon Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 17544 · added 2026-10-26 · link last verified 2026-10-26 · confidence high

Similar investors

Listed under